Herceptin May Be of Little Use in Immune Cell-Heavy Breast Cancer

Share this content:
Herceptin May Be of Little Use in Immune Cell-Heavy Breast Ca
Herceptin May Be of Little Use in Immune Cell-Heavy Breast Ca
HER2-positive breast cancers with a high level of immune cell infiltration might not benefit from the addition of trastuzumab (Herceptin) to chemotherapy, a trial analysis suggested. The 10% of patients with stromal tumor-infiltrating lymphocyte-predominant breast cancer in the ...
READ FULL ARTICLE From Medical Page Today
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »